Jiangsu Pacific minok bio Pharmaceutical Co., Ltd
  • Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial
    CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells
    Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial
    Basolateral CD147 Induces Hepatocyte Polarity Loss
    by E-cadherin Ubiquitination and Degradation in Hepatocellular Carcinoma Progress
    Disrupting CD147-RAP2 interaction abrogates erythrocyte invasion
    by Plasmodium falciparum
    Randomized Trial of [] Metuximab in Treatment of Hepatocellular Carcinoma After Percutaneous Radiofrequency Ablation
    Stay up to date on Pacific Meinuoke
    © Pacific Meinuoke         Legal Notice       苏ICP备10218680号-1